He highlighted strong contributions from acquisitions, which added 11.9% to quarterly revenue. Laukien emphasized that Bruker continues to benefit from its portfolio transformation, particularly ...

Finally, we expect non-GAAP EPS growth of 11% to 13%, with 14% to 16% constant exchange rate, EPS growth, all compared to '24. Turning to Slide 4 now. In the fourth quarter of '24, Bruker ...

Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

The company anticipates organic revenue growth of 3-4% and a non-GAAP EPS range of $2.67 to $2.72, representing an 11-13% increase. Bruker remains optimistic about gradual recovery in the ...

BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

The Axion Longitudinal Plasma Haloscope (ALPHA) experiment reached a milestone on February 24 with the successful ...

Siemens unveiled the two photon-counting CTs in December. GE HealthCare and Philips Healthcare are developing their own ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation ... massive growth potential. • 11 New Issues of Our Premium ...